The NIH Inclusion Across the Lifespan Policy was evaluated to determine its impact on the representation of older adults in US interventional cardiovascular disease trials.
Does the National Institutes of Health’s Inclusion Across the Lifespan Policy improve the representation of older adults in interventional cardiovascular disease studies in the US?
This review evaluates whether the NIH Inclusion Across the Lifespan Policy successfully improved the representation of older adults in US cardiovascular trials.
Tasa de eventos absoluta: 0% vs 0%
This review compares representation of older adults in interventional cardiovascular disease studies in the US before and after implementation of the National Institutes of Health’s Inclusion Across the Lifespan Policy.
Nanna et al. (Tue,) reported a other. The NIH Inclusion Across the Lifespan Policy was evaluated to determine its impact on the representation of older adults in US interventional cardiovascular disease trials.